Lisdexamfetamine Dimesylate Capsule shortage
Current 90 presentations · 13 manufacturers · first FDA posting 2023-07-14 · last update 2026-10-15
Manufacturers: Alvogen, Amneal Pharmaceuticals, Apotex Corp., Elite Laboratories, Inc., Hikma Pharmaceuticals USA, Inc., Lannett Company, Inc., Mylan Pharmaceuticals Inc., a Viatris Company, Rhodes Pharmaceuticals L.P., Solco Healthcare US, LLC, SpecGx LLC, Sun Pharmaceutical Industries, Inc., Takeda Pharmaceuticals USA Inc., Teva Pharmaceuticals USA, Inc.
Stated reasons (per FDA): Delay in shipping of the drug; Other; Shortage of an active ingredient
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 47781-562-01) | Alvogen | Current Available |
— | Posted 07/14/2023 Updated 10/02/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 47781-563-01) | Alvogen | Current Available |
— | Posted 07/14/2023 Updated 10/02/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 47781-564-01) | Alvogen | Current Available |
— | Posted 07/14/2023 Updated 10/02/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 47781-565-01) | Alvogen | Current Available |
— | Posted 07/14/2023 Updated 10/02/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 47781-566-01) | Alvogen | Current Available |
— | Posted 07/14/2023 Updated 10/02/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 47781-567-01) | Alvogen | Current Available |
— | Posted 07/14/2023 Updated 10/02/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 47781-568-01) | Alvogen | Current Available |
— | Posted 07/14/2023 Updated 10/02/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 65162-023-09) | Amneal Pharmaceuticals | Current Available |
— | Posted 07/14/2023 Updated 10/06/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 65162-024-09) | Amneal Pharmaceuticals | Current Available |
— | Posted 07/14/2023 Updated 10/06/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 65162-025-09) | Amneal Pharmaceuticals | Current Available |
— | Posted 07/14/2023 Updated 10/06/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 65162-026-09) | Amneal Pharmaceuticals | Current Available |
— | Posted 07/14/2023 Updated 10/06/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 65162-027-09) | Amneal Pharmaceuticals | Current Available |
— | Posted 07/14/2023 Updated 10/06/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 65162-028-09) | Amneal Pharmaceuticals | Current Available |
— | Posted 07/14/2023 Updated 10/06/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 60505-4739-1) | Apotex Corp. | Current Available |
— | Posted 11/01/2023 Updated 10/15/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 60505-4740-1) | Apotex Corp. | Current Unavailable |
Delay in shipping of the drug | Estimated recovery: 9/25/26 | Posted 11/01/2023 Updated 09/16/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 60505-4741-1) | Apotex Corp. | Current Available |
— | Posted 11/01/2023 Updated 10/15/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 60505-4742-1) | Apotex Corp. | Current Available |
— | Posted 11/01/2023 Updated 10/15/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 60505-4743-1) | Apotex Corp. | Current Available |
— | Posted 11/01/2023 Updated 10/15/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 60505-4744-1) | Apotex Corp. | Current Available |
— | Posted 11/01/2023 Updated 10/15/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 60505-4745-1) | Apotex Corp. | Current Available |
— | Posted 11/01/2023 Updated 10/15/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 64850-550-01) | Elite Laboratories, Inc. | Current Limited Availability |
Shortage of an active ingredient | Estimated recovery: TBD | Posted 07/14/2023 Updated 10/15/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 64850-551-01) | Elite Laboratories, Inc. | Current Limited Availability |
Shortage of an active ingredient | Estimated recovery: TBD | Posted 07/14/2023 Updated 10/15/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 64850-552-01) | Elite Laboratories, Inc. | Current Limited Availability |
Shortage of an active ingredient | Estimated recovery: TBD | Posted 07/14/2023 Updated 10/15/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 64850-553-01) | Elite Laboratories, Inc. | Current Limited Availability |
Shortage of an active ingredient | Estimated recovery: TBD | Posted 07/14/2023 Updated 10/15/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 64850-554-01) | Elite Laboratories, Inc. | Current Limited Availability |
Shortage of an active ingredient | Estimated recovery: TBD | Posted 07/14/2023 Updated 10/15/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 64850-555-01) | Elite Laboratories, Inc. | Current Limited Availability |
Shortage of an active ingredient | Estimated recovery: TBD | Posted 07/14/2023 Updated 10/15/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 64850-556-01) | Elite Laboratories, Inc. | Current Limited Availability |
Shortage of an active ingredient | Estimated recovery: TBD | Posted 07/14/2023 Updated 10/15/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0054-0370-25) | Hikma Pharmaceuticals USA, Inc. | Current Limited Availability |
Shortage of an active ingredient | Available on allocation | Posted 07/14/2023 Updated 10/14/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0054-0371-25) | Hikma Pharmaceuticals USA, Inc. | Current Limited Availability |
Shortage of an active ingredient | Available on allocation | Posted 07/14/2023 Updated 10/14/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0054-0372-25) | Hikma Pharmaceuticals USA, Inc. | Current Limited Availability |
Shortage of an active ingredient | Available on allocation | Posted 07/14/2023 Updated 10/14/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0054-0373-25) | Hikma Pharmaceuticals USA, Inc. | Current Limited Availability |
Shortage of an active ingredient | Available on allocation | Posted 07/14/2023 Updated 10/14/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0054-0374-25) | Hikma Pharmaceuticals USA, Inc. | Current Limited Availability |
Shortage of an active ingredient | Available on allocation | Posted 07/14/2023 Updated 10/14/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0054-0375-25) | Hikma Pharmaceuticals USA, Inc. | Current Limited Availability |
Shortage of an active ingredient | Available on allocation | Posted 07/14/2023 Updated 10/14/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0054-0660-25) | Hikma Pharmaceuticals USA, Inc. | Current Limited Availability |
Shortage of an active ingredient | Available on allocation | Posted 07/14/2023 Updated 05/12/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0527-4661-37) | Lannett Company, Inc. | Current Available |
— | Posted 07/14/2023 Updated 10/15/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0527-4662-37) | Lannett Company, Inc. | Current Available |
— | Posted 07/14/2023 Updated 10/01/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0527-4663-37) | Lannett Company, Inc. | Current Available |
— | Posted 07/14/2023 Updated 10/01/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0527-4664-37) | Lannett Company, Inc. | Current Available |
— | Posted 07/14/2023 Updated 10/01/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0527-4665-37) | Lannett Company, Inc. | Current Available |
— | Posted 07/14/2023 Updated 10/15/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0527-4666-37) | Lannett Company, Inc. | Current Available |
— | Posted 09/20/2023 Updated 10/15/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0527-4667-37) | Lannett Company, Inc. | Current Available |
— | Posted 07/14/2023 Updated 10/15/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0378-6854-77) | Mylan Pharmaceuticals Inc., a Viatris Company | Current Available |
— | Posted 07/14/2023 Updated 10/05/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0378-6855-77) | Mylan Pharmaceuticals Inc., a Viatris Company | Current Available |
— | Posted 07/14/2023 Updated 10/05/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0378-6856-77) | Mylan Pharmaceuticals Inc., a Viatris Company | Current Available |
— | Posted 07/14/2023 Updated 10/05/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0378-6857-77) | Mylan Pharmaceuticals Inc., a Viatris Company | Current Available |
— | Posted 07/14/2023 Updated 10/05/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0378-6858-77) | Mylan Pharmaceuticals Inc., a Viatris Company | Current Available |
— | Posted 07/14/2023 Updated 10/05/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0378-6859-77) | Mylan Pharmaceuticals Inc., a Viatris Company | Current Available |
— | Posted 07/14/2023 Updated 10/05/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0378-6860-77) | Mylan Pharmaceuticals Inc., a Viatris Company | Current Available |
— | Posted 07/14/2023 Updated 10/05/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 42858-161-01) | Rhodes Pharmaceuticals L.P. | Current Available |
— | Posted 07/14/2023 Updated 06/24/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 42858-162-01) | Rhodes Pharmaceuticals L.P. | Current Limited Availability |
Shortage of an active ingredient | Estimated recovery: TBD | Posted 07/14/2023 Updated 06/24/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 42858-163-01) | Rhodes Pharmaceuticals L.P. | Current Limited Availability |
Shortage of an active ingredient | Estimated recovery: TBD | Posted 07/14/2023 Updated 06/24/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 42858-164-01) | Rhodes Pharmaceuticals L.P. | Current Limited Availability |
Shortage of an active ingredient | Estimated recovery: TBD | Posted 07/14/2023 Updated 06/24/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 42858-165-01) | Rhodes Pharmaceuticals L.P. | Current Limited Availability |
Shortage of an active ingredient | Estimated recovery: TBD | Posted 07/14/2023 Updated 06/24/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 42858-166-01) | Rhodes Pharmaceuticals L.P. | Current Available |
— | Posted 07/14/2023 Updated 06/24/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 42858-167-01) | Rhodes Pharmaceuticals L.P. | Current Limited Availability |
Shortage of an active ingredient | Estimated recovery: TBD | Posted 01/11/2024 Updated 06/24/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 43547-602-10) | Solco Healthcare US, LLC | Current Limited Availability |
Shortage of an active ingredient | On allocation | Posted 07/14/2023 Updated 06/29/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 43547-603-10) | Solco Healthcare US, LLC | Current Limited Availability |
Shortage of an active ingredient | On allocation | Posted 07/14/2023 Updated 06/29/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 43547-604-10) | Solco Healthcare US, LLC | Current Limited Availability |
Shortage of an active ingredient | On allocation | Posted 07/14/2023 Updated 06/29/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 43547-605-10) | Solco Healthcare US, LLC | Current Limited Availability |
Shortage of an active ingredient | On allocation | Posted 07/14/2023 Updated 06/29/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 43547-606-10) | Solco Healthcare US, LLC | Current Limited Availability |
Shortage of an active ingredient | On allocation | Posted 07/14/2023 Updated 06/29/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 43547-607-10) | Solco Healthcare US, LLC | Current Limited Availability |
Shortage of an active ingredient | On allocation | Posted 07/14/2023 Updated 06/29/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 43547-608-10) | Solco Healthcare US, LLC | Current Limited Availability |
Shortage of an active ingredient | On allocation | Posted 07/14/2023 Updated 06/29/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0406-5111-01) | SpecGx LLC | Current Available |
— | Posted 07/14/2023 Updated 08/20/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0406-5112-01) | SpecGx LLC | Current Available |
— | Posted 07/14/2023 Updated 08/20/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0406-5113-01) | SpecGx LLC | Current Available |
— | Posted 07/14/2023 Updated 08/20/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0406-5114-01) | SpecGx LLC | Current Available |
— | Posted 07/14/2023 Updated 08/20/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0406-5115-01) | SpecGx LLC | Current Available |
— | Posted 07/14/2023 Updated 08/20/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0406-5116-01) | SpecGx LLC | Current Available |
— | Posted 07/14/2023 Updated 08/20/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0406-5117-01) | SpecGx LLC | Current Available |
— | Posted 07/14/2023 Updated 08/20/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 57664-046-88) | Sun Pharmaceutical Industries, Inc. | Current Limited Availability |
Other | Estimated Recovery: TBD | Posted 07/14/2023 Updated 09/18/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 57664-047-88) | Sun Pharmaceutical Industries, Inc. | Current Limited Availability |
Other | Estimated Recovery: TBD | Posted 07/14/2023 Updated 09/18/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 57664-047-88) | Sun Pharmaceutical Industries, Inc. | Current Limited Availability |
Other | Estimated Recovery: TBD | Posted 07/14/2023 Updated 09/18/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 57664-049-88) | Sun Pharmaceutical Industries, Inc. | Current Limited Availability |
Other | Estimated Recovery: TBD | Posted 07/14/2023 Updated 09/18/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 57664-050-88) | Sun Pharmaceutical Industries, Inc. | Current Limited Availability |
Other | Estimated Recovery: TBD | Posted 07/14/2023 Updated 09/18/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 57664-051-88) | Sun Pharmaceutical Industries, Inc. | Current Limited Availability |
Other | Estimated Recovery: TBD | Posted 07/14/2023 Updated 09/18/2026 |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 57664-052-88) | Sun Pharmaceutical Industries, Inc. | Current Limited Availability |
Other | Estimated Recovery: TBD | Posted 07/14/2023 Updated 09/18/2026 |
| Vyvanse, Capsule, 10 mg (NDC 59417-101-10) | Takeda Pharmaceuticals USA Inc. | Current Available |
— | Posted 07/14/2023 Updated 10/15/2026 | |
| Vyvanse, Capsule, 20 mg (NDC 59417-102-10) | Takeda Pharmaceuticals USA Inc. | Current Available |
— | Posted 07/14/2023 Updated 10/15/2026 | |
| Vyvanse, Capsule, 30 mg (NDC 59417-103-10) | Takeda Pharmaceuticals USA Inc. | Current Available |
— | Posted 07/14/2023 Updated 10/15/2026 | |
| Vyvanse, Capsule, 40 mg (NDC 59417-104-10) | Takeda Pharmaceuticals USA Inc. | Current Available |
— | Posted 07/14/2023 Updated 10/15/2026 | |
| Vyvanse, Capsule, 50 mg (NDC 59417-105-10) | Takeda Pharmaceuticals USA Inc. | Current Available |
— | Posted 07/14/2023 Updated 10/15/2026 | |
| Vyvanse, Capsule, 60 mg (NDC 59417-106-10) | Takeda Pharmaceuticals USA Inc. | Current Available |
— | Posted 07/14/2023 Updated 10/15/2026 | |
| Vyvanse, Capsule, 70 mg (NDC 59417-107-10) | Takeda Pharmaceuticals USA Inc. | Current Available |
— | Posted 07/14/2023 Updated 10/15/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0480-3564-01) | Teva Pharmaceuticals USA, Inc. | Current Available |
— | Posted 07/14/2023 Updated 10/15/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0480-3565-01) | Teva Pharmaceuticals USA, Inc. | Current Available |
— | Posted 07/14/2023 Updated 10/15/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0480-3566-01) | Teva Pharmaceuticals USA, Inc. | Current Available |
— | Posted 07/14/2023 Updated 10/15/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0480-3567-01) | Teva Pharmaceuticals USA, Inc. | Current Available |
— | Posted 07/14/2023 Updated 10/15/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0480-3568-01) | Teva Pharmaceuticals USA, Inc. | Current Available |
— | Posted 07/14/2023 Updated 10/15/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0480-3569-01) | Teva Pharmaceuticals USA, Inc. | Current Available |
— | Posted 07/14/2023 Updated 10/15/2026 | |
| Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0480-3570-01) | Teva Pharmaceuticals USA, Inc. | Current Available |
— | Posted 07/14/2023 Updated 10/15/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)